Roy M Graham

US Patent:

20080058250, Mar 6, 2008

Filed:

Aug 17, 2006

Appl. No.:

11/465442

Inventors:

Allison Wren - Reno NV, US
Roy Graham - Incline Village NV, US
Randy McElreath - Reno NV, US
Michael Molnar - Summerfield NC, US

International Classification:

A61K 38/04
A61K 31/135
A61K 31/164
A61K 31/40
A61P 43/00
A61K 31/44
A61K 31/55
A61K 31/59

US Classification:

514 8, 514167, 51421207, 514356, 514423, 514620, 514650

Abstract:

The present invention generally concerns the management of age-related diseases in domestic animals. Specifically, the present invention is directed to combination therapies for the treatment of progressive renal diseases (e.g., Chronic Renal Failure) and their accompanying secondary disease states. In a composition aspect, the present invention provides a composition comprising a phosphate binder and another pharmaceutically active ingredient. The other pharmaceutically active ingredient is selected from a group consisting of antihypertensives, calcitrol, vitamin D analogues, lipid restriction products, potassium salts, treatments for anemia and alkalization compounds.

US Patent:

20080069860, Mar 20, 2008

Filed:

Aug 17, 2006

Appl. No.:

11/465445

Inventors:

Allison Wren - Reno NV, US
Roy Graham - Incline Village NV, US
Randy McElreath - Reno NV, US
Michael Molnar - Summerfield NC, US

International Classification:

A61K 47/00
A21D 2/00
A23L 1/00
A23L 1/10
A23L 1/31
A23L 1/315
A23L 1/317
A61P 7/00
A23L 1/32
A23L 1/325
A23L 1/326
A23L 1/36
A61K 31/28

US Classification:

424439, 426614, 426615, 426618, 426622, 426629, 426641, 426643, 426644, 426646, 514492

Abstract:

The present invention is generally related to the treatment of hyperphosphatemia in domestic animals. It is specifically directed to compositions containing phosphate binders that are palatable to domestic animals and methods using such compositions. In a composition aspect, the present invention provides a composition that includes: a rare earth compound (e.g., lanthanum oxycarbonate or lanthanum carbonate hydroxide), calcium salts (e.g, calcium carbonate or calcium acetate), aluminum salts (e.g., aluminum hydroxide or a hydrophilic exchange resin; and an ingredient of domestic animal food, wherein the ingredient is selected from a group consisting of chicken, beef, lamb, chicken meal or lamb meal, corn, rice, bone meal, fish meal, fish, egg product, beef, beef meal, corn gluten meal, poultry by-product meal, wheat flour, beef tallow, maple syrup, honey, apple, flaxseed, flaxseed meal, rice bran and germ, oats, barley, and wheat bran.

US Patent:

20090317352, Dec 24, 2009

Filed:

Aug 28, 2009

Appl. No.:

12/549758

Inventors:

Allison Wren - Reno NV, US
Roy Graham - Incline Village NV, US
Randy McElreath - Reno NV, US
Michael Molnar - Summerfield NC, US

Assignee:

ALTAIRNANO, INC. - Reno NV

International Classification:

A61K 31/785

US Classification:

424 7801

Abstract:

The present invention is generally related to the treatment of hyperphosphatemia in domestic animals. It is specifically directed to compositions containing phosphate binders that are palatable to domestic animals and methods using such compositions. In a composition aspect, the present invention provides a composition that includes: a rare earth compound (e.g., lanthanum oxycarbonate or lanthanum carbonate hydroxide), calcium salts (e.g, calcium carbonate or calcium acetate), aluminum salts (e.g., aluminum hydroxide or a hydrophilic exchange resin; and an ingredient of domestic animal food, wherein the ingredient is selected from a group consisting of chicken, beef, lamb, chicken meal or lamb meal, corn, rice, bone meal, fish meal, fish, egg product, beef, beef meal, corn gluten meal, poultry by-product meal, wheat flour, beef tallow, maple syrup, honey, apple, flaxseed, flaxseed meal, rice bran and germ, oats, barley, and wheat bran.

US Patent:

20100104664, Apr 29, 2010

Filed:

Dec 21, 2009

Appl. No.:

12/643518

Inventors:

Allison Wren - Reno NV, US
Roy Graham - Incline Village NV, US
Randy McElreath - Reno NV, US
Michael Molnar - Summerfield NC, US

International Classification:

A61K 31/59
A61K 31/19
A61K 33/10
A61K 33/08
A61K 31/40
A61K 31/55
A61K 31/165
A61K 31/138
A61K 31/4422
A61K 38/00

US Classification:

424687, 514167, 424715, 514557, 424690, 514423, 51421207, 514620, 514652, 514356, 514 8

Abstract:

The present invention generally concerns the management of age-related diseases in domestic animals. Specifically, the present invention is directed to combination therapies for the treatment of progressive renal diseases (e.g., Chronic Renal Failure) and their accompanying secondary disease states. In a composition aspect, the present invention provides a composition comprising a phosphate binder and another pharmaceutically active ingredient. The other pharmaceutically active ingredient is selected from a group consisting of antihypertensives, calcitrol, vitamin D analogues, lipid restriction products, potassium salts, treatments for anemia and alkalization compounds.